There has been a drastic drop in the number of breast cancer screenings since the start of the pandemic, which is concerning because early detection is key.
Doctors are worried the resurgence of COVID-19 could lead to more delayed or canceled screenings.
“We’re still way behind,” said Dr. Larry Gassner, MDVIP internal medicine physician. “The numbers were 80 to 90% down.”
